Illumina (ILMN) financial statements

Healthcare · Diagnostics & Research · Market cap $41.1B

Illumina reported revenue of $4.3B in fiscal 2025, up 6.8% a year over 9 years.

Net income was $850M and the operating margin 18.6%, against 24.5% in 2016.

Free cash flow was $931M, and the company returned $742M in net buybacks.

The diluted share count rose 5% over the period (dilution).

Revenue and free cash flow

Fiscal years, $ billions.

02462016201720182019202020212022202320242025RevenueFree cash flow
Embed this chart

Free to use in articles and newsletters with the source line. Paste this HTML:

Income statement

Fiscal years, from Illumina's 10-K filings with the SEC.

Fiscal year2016201720182019202020212022202320242025
Revenue$2.4B$2.8B$3.3B$3.5B$3.2B$4.5B$4.6B$4.5B$4.4B$4.3B
Cost of revenue$732M$926M$1.0B$1.1B$1.0B$1.4B$1.6B$1.8B$1.5B$1.5B
Gross profit$1.7B$1.8B$2.3B$2.5B$2.2B$3.2B$3.0B$2.7B$2.9B$2.9B
Research and development$504M$546M$623M$647M$682M$1.2B$1.3B$1.4B$1.2B$967M
Selling, general and admin$584M$674M$794M$835M$941M$2.1B$1.3B$1.6B$1.1B$1.1B
Operating income$587M$606M$883M$985M$580M-$123M-$4.2B-$1.1B-$833M$807M
Interest expense$33M$37M$57M$52M$49M$61M$26M$77M$100M$101M
Pre-tax income$561M$1.0B$894M$1.1B$856M$884M-$4.3B-$1.1B-$1.2B$1.1B
Income tax$133M$365M$112M$128M$200M$122M$68M$44M$44M$236M
Net income$463M$726M$826M$1.0B$656M$762M-$4.4B-$1.2B-$1.2B$850M
EPS (diluted)$3.07$4.92$5.56$6.74$4.45$5.04-$28.00-$7.34-$7.69$5.45
Diluted shares148M148M149M149M148M151M157M158M159M156M
Gross margin69.5%66.4%69.0%69.6%68.0%69.7%64.8%60.9%65.4%66.1%
Operating margin24.5%22.0%26.5%27.8%17.9%-2.7%-91.2%-23.7%-19.1%18.6%
Net margin19.3%26.4%24.8%28.3%20.3%16.8%-96.1%-25.8%-28.0%19.6%

Balance sheet

Fiscal years, from Illumina's 10-K filings with the SEC.

Fiscal year2016201720182019202020212022202320242025
Cash and short-term investments$1.6B$2.1B$3.5B$3.4B$3.5B$1.3B$2.0B$1.1B$1.2B$1.6B
Receivables$381M$411M$514M$573M$487M$648M$671M$734M$735M$854M
Inventory$300M$333M$386M$359M$372M$431M$568M$587M$547M$564M
Total current assets$2.3B$3.0B$4.5B$4.5B$4.5B$2.7B$3.6B$2.6B$2.7B$3.3B
Property, plant and equipment$713M$931M$1.1B$889M$922M$1.0B$1.1B$1.0B$815M$759M
Goodwill$776M$771M$831M$897M$897M$7.1B$3.2B$2.5B$1.1B$1.1B
Total assets$4.3B$5.3B$7.0B$7.3B$7.6B$15.2B$12.3B$10.1B$6.3B$6.6B
Total current liabilities$705M$746M$1.8B$665M$1.2B$1.1B$2.8B$1.6B$1.5B$1.6B
Long-term debt$1.1B$1.2B$890M$1.1B$673M—————
Total liabilities$2.0B$2.5B$3.1B$2.7B$2.9B$4.5B$5.7B$4.4B$3.9B$3.9B
Shareholders' equity$2.2B$2.7B$3.8B$4.6B$4.7B$10.7B$6.6B$5.7B$2.4B$2.7B
Net debt$323M-$33M$853M-$901M-$626M-$1.2B-$2.0B-$1.0B-$1.1B-$1.4B

Cash flow

Fiscal years, from Illumina's 10-K filings with the SEC.

Fiscal year2016201720182019202020212022202320242025
Operating cash flow$779M$875M$1.1B$1.1B$1.1B$545M$392M$478M$837M$1.1B
Capital spending$260M$310M$296M$209M$189M$208M$286M$195M$128M$148M
Free cash flow$519M$565M$846M$842M$891M$337M$106M$283M$709M$931M
Stock-based compensation$129M$164M$193M$194M$194M$754M$366M$380M$370M$275M
Share buybacks (net)-$249M-$251M-$201M-$324M-$736M$0$0$0-$116M-$742M
Net borrowing$5M$5M$735M$0$0$988M$991M$0$1.2B$495M
Free cash flow margin21.6%20.5%25.4%23.8%27.5%7.4%2.3%6.3%16.2%21.4%
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for ILMN.
Open ILMN in Investingly

Questions

What was Illumina's revenue in 2025?

$4.3B in fiscal 2025, from its 10-K filing.

How much free cash flow does Illumina generate?

$931M in fiscal 2025 (operating cash flow minus capital spending).

From Illumina's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.